Cognitive Assessment And Training In Healthcare Market Size, Share | Report 2022-2030
The global cognitive assessment and training in healthcare market was surpassed at USD 3.42 billion in 2021 and is expected to hit around USD 26.67 billion by 2030, growing at a CAGR of 25.64% from 2022 to 2030.
Report Highlights
Healthcare professionals use cognitive assessment to evaluate patients who exhibit loss of memory or other signs of cognitive impairment. These assessments are helpful in screening for a variety of illnesses including Parkinson's disease, brain tumors, and stroke-related cognitive problems, and identifying patients who are at risk of developing dementia. The rise in incidence rates of dementia cases, increasing awareness regarding cognitive health, and technologically advanced cognitive assessments & training tools remain key factors for growth. Moreover, increased application of cognitive assessments in clinical trials and dementia research are also other factors driving the growth of the market.
The COVID-19 pandemic affected the market with a reduction in emergency visits and significantly delayed outpatient clinic appointments. In addition, consultation services that involve one-on-one interaction were hampered due to concerns about transmission. The market players suffered losses in the initial phase. However, telemedicine and online platforms for cognitive testing and training created new revenue streams to mitigate some of those losses. As a result, cutting-edge technologies such as remote (decentralized) clinical trials and home-based assessments have been adopted at an unprecedented rate.
The demand for brain assessment training by the tech-savvy generation and the expanding market for cognitive solutions are both driving the rise of the cognitive assessment and training sector. Due to the advancement of technology, brain training activities have been steadily incorporated into computerized training on smartphones and tablets, computers, and more recently, gaming consoles. Some brain training regimens focus on particular cognitive skills, while others are more comprehensive and interconnected. Programs for cognitive training may include manipulatives; additional support, such as playing cards; physical activity; tasks requiring paper and pencil; computer-based exercises; and other training techniques.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 3.42 billion |
| Revenue Forecast by 2030 | USD 26.67 billion |
| Growth rate from 2022 to 2030 | CAGR of 25.64% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Assessment, component, application, region |
| Companies Covered |
Cambridge Cognition Ltd.; CogniFit Inc.; Cogstate Ltd.; CNS Vital Signs, LLC; Brain Resource Company; WIRB-Copernicus Group; Quest Diagnostics Incorporated; Signant Health; Posit Science; Clario; Cognetivity Neurosciences |
Assessment Insights
The pen & paper-based assessment segment dominated the market with a revenue share of 47.72% in 2021 owing to easy availability and affordability. Although they require more time to administer, they offer the advantage of testing more cognitive capabilities. The results of the tests, which evaluate different aspects of cognitive functioning including short-term memory, attention, concentration, working memory, visual-spatial ability, reaction time, and information processing speed, can help clinicians to gauge the severity of a brain injury and cognitive impairment.
The hosted assessment segment is expected to witness a CAGR of 26.62% over the forecast period owing to better access to technology, growing adoption of telehealth, and increasing adoption of mobile technology for gamification in cognitive assessment and training. In addition, computerized cognitive assessments continue to become reimbursable over time using CPT codes due to the latest advancements in neuropsychological testing. Hosted assessment makes it possible for a medical assistant as well as other non-specialized staff members to deliver assessments reliably, potentially assisting neurologists in doing better assessments and treating more patients.
Component Insights
In 2021, the services component held the largest revenue share of 59.4% owing to an increase in the demand for advanced services offered by market players. Companies are offering services such as training & support, and consulting for rater qualification, training, and management that equip raters to administer scales most efficiently while adhering to the highest standards. For instance, the experimental technique used by Cogstate, a U.S.-based company, removes pointless training, makes use of a tailored eLearning curriculum, lessens the burden of rater certification, and speeds up the commencement of a study.
The solution segment is expected to witness a CAGR of 25.64% over the forecast period, owing to an increase in the number of technologically advanced solutions offered by market players. Various solutions offered by businesses are digital assessments, data analysis & reporting, and data management. Market players offer online data management solutions in addition to digital cognitive assessment tools for effective data storage and continuing management of data discrepancies. Researchers and healthcare professionals can instantly access the results after uploading cognitive test data, enabling effective review, cleaning, and analysis.
Application Insights
The clinical trials segment held a majority of the revenue share of 41.04% in 2021 and is expected to retain its position during the forecast period. Clinical testing of drug safety and efficacy is extremely difficult when treating the central nervous system. Study teams can improve the success rate of their trials by using cognitive assessments to make quicker and more informed judgments about their potential therapeutic drug. Numerous organizations provide objective assessments and solutions that aid thousands of researchers working on different symptoms and stages of the development of any drug. Market players support clinical trials by providing validated and sensitive computerized cognitive assessments tested rater training and data quality systems.
The screening & diagnostics segment is likely to witness a significant CAGR of 25.78% over the forecast period. Cognitive assessments are ideal as an effective screening tool to support collaboration with neuropsychologists, neurosurgeons, and other specialists in order to make evidence-based decisions about the next-best steps in the treatment of a patient. Neurologists can more effectively pinpoint deficiencies and strengthen the help in diagnosis and subsequently monitor recovery as therapy continues with the help of a quantitative assessment of a patient's brain health.
Regional Insights
North America held a leading revenue share of 37.92% in 2021. The increasing prevalence of dementia, the adoption of technologically advanced assessment tools, and significant expenditure on cognitive research are some of the factors attributed to the market growth. There has been a steady growth in the number of patients with cognitive impairment in the region, fueling the demand for cognitive assessment. Government initiatives such as Aging's Alzheimer's Disease Supportive Services Program support state efforts to develop adaptive, comprehensive, and sustainable service delivery systems for patients with Alzheimer's disease.
Asia Pacific is expected to expand at the fastest CAGR of 26.54% during the forecast period due to the rising geriatric population, increasing prevalence of dementia, increasing incidence of sports injuries & trauma leading to cognitive impairment, rapidly expanding healthcare infrastructure, and growing government support.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cognitive Assessment And Training In Healthcare Market
5.1. COVID-19 Landscape: Cognitive Assessment And Training In Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cognitive Assessment And Training In Healthcare Market, By Assessment
8.1. Cognitive Assessment And Training In Healthcare Market, by Assessment, 2022-2030
8.1.1 Biometrics Assessment
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pen & Paper-based Assessment
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Hosted Assessment
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cognitive Assessment And Training In Healthcare Market, By Component
9.1. Cognitive Assessment And Training In Healthcare Market, by Component, 2022-2030
9.1.1. Solution
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Services
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cognitive Assessment And Training In Healthcare Market, By Application
10.1. Cognitive Assessment And Training In Healthcare Market, by Application, 2022-2030
10.1.1. Clinical Trials
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Screening & Diagnostics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Brain Training
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Academic Research
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cognitive Assessment And Training In Healthcare Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.1.2. Market Revenue and Forecast, by Component (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Component (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Component (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.2.2. Market Revenue and Forecast, by Component (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Component (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Component (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Component (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Component (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.3.2. Market Revenue and Forecast, by Component (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Component (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Component (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Component (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Component (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.4.2. Market Revenue and Forecast, by Component (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Component (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Component (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Component (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Component (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.5.2. Market Revenue and Forecast, by Component (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Component (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Assessment (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Component (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
Chapter 12. Company Profiles
12.1. Cambridge Cognition Ltd
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. CogniFit Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Cogstate Ltd
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. CNS Vital Signs, LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Brain Resource Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. WIRB-Copernicus Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Quest Diagnostics Incorporated
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Signant Health
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Posit Science
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Clario
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers